chronic condition management

Healthcare provider on a tablet
DarioHealth closes $25.6M private placement of convertible preferred stock
By Anthony Vecchione | 02:08 pm | January 21, 2025
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.